• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

死于(伴发)还是死于?开发和测试一种SARS-CoV-2意义评分以评估COVID-19在受影响患者死亡中的作用。

Died with or Died of? Development and Testing of a SARS CoV-2 Significance Score to Assess the Role of COVID-19 in the Deaths of Affected Patients.

作者信息

Giorgetti Arianna, Orazietti Vasco, Busardò Francesco Paolo, Pirani Filippo, Giorgetti Raffaele

机构信息

Department of Medical and Surgical Sciences, Unit of Legal Medicine, University of Bologna, Via Irnerio 49, 40126 Bologna, Italy.

Department of Excellence of Biomedical Sciences and Public Health, University "Politecnica delle Marche" of Ancona, via Conca 71, 60126 Ancona, Italy.

出版信息

Diagnostics (Basel). 2021 Jan 28;11(2):190. doi: 10.3390/diagnostics11020190.

DOI:10.3390/diagnostics11020190
PMID:33525705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7912253/
Abstract

Since December 2019, a new form of coronavirus, SARS-CoV-2, has spread from China to the whole word, raising concerns regarding Coronavirus Disease 2019 (COVID-19) endangering public health and life. Over 1.5 million deaths related with COVID-19 have been recorded worldwide, with wide variations among countries affected by the pandemic and continuously growing numbers. The aim of this paper was to provide an overview of the literature cases of deaths involving COVID-19 and to evaluate the application of the COVID-19 Significance Score (CSS) in the classification of SARS CoV-2-related fatalities, comparing it with the Hamburg rating scale. The results obtained allowed us to highlight that CSS used after a complete accurate post-mortem examination, coupled to the retrieval of in vivo data, post-mortem radiology, histology and toxicology, as well as to additional required analyses (e.g., electronic microscopy) is a useful and concise tool in the assessment of the cause of death and the role played by this virus. A shared use of this scale might hopefully lower the inhomogeneities in forensic evaluation of SARS CoV-2-related fatalities.

摘要

自2019年12月以来,一种新型冠状病毒——严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已从中国传播至全球,引发了对2019冠状病毒病(COVID-19)危及公众健康和生命的担忧。全球已记录了超过150万例与COVID-19相关的死亡病例,在受该疫情影响的国家中差异很大,且数量持续增长。本文的目的是概述涉及COVID-19的死亡病例文献,并评估COVID-19重要性评分(CSS)在SARS-CoV-2相关死亡病例分类中的应用,将其与汉堡评分量表进行比较。所得结果使我们能够强调,在进行完整准确的尸检后使用CSS,并结合体内数据、尸检放射学、组织学和毒理学以及其他所需分析(如电子显微镜检查),是评估死亡原因以及该病毒所起作用的一种有用且简洁的工具。共同使用该量表有望降低SARS-CoV-2相关死亡病例法医评估中的不均匀性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fe/7912253/5457ac310bad/diagnostics-11-00190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fe/7912253/74e201daf78b/diagnostics-11-00190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fe/7912253/5457ac310bad/diagnostics-11-00190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fe/7912253/74e201daf78b/diagnostics-11-00190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fe/7912253/5457ac310bad/diagnostics-11-00190-g002.jpg

相似文献

1
Died with or Died of? Development and Testing of a SARS CoV-2 Significance Score to Assess the Role of COVID-19 in the Deaths of Affected Patients.死于(伴发)还是死于?开发和测试一种SARS-CoV-2意义评分以评估COVID-19在受影响患者死亡中的作用。
Diagnostics (Basel). 2021 Jan 28;11(2):190. doi: 10.3390/diagnostics11020190.
2
Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.2020 年 3 月 11 日至 5 月 2 日期间 COVID-19 爆发期间超额死亡的初步估计-纽约市。
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605. doi: 10.15585/mmwr.mm6919e5.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.2020 年 3 月至 2021 年 12 月英格兰儿童和青少年的 COVID-19 死亡病例:一项主动的全国前瞻性监测研究。
PLoS Med. 2022 Nov 8;19(11):e1004118. doi: 10.1371/journal.pmed.1004118. eCollection 2022 Nov.
5
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
6
Potentials of post-mortem CT investigations during SARS-COV-2 pandemic: a narrative review.SARS-CoV-2 大流行期间尸检 CT 研究的潜力:叙述性综述。
Radiol Med. 2022 Apr;127(4):383-390. doi: 10.1007/s11547-022-01457-w. Epub 2022 Feb 28.
7
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
8
Cause of death based on systematic post-mortem studies in patients with positive SARS-CoV-2 tissue PCR during the COVID-19 pandemic.基于在 COVID-19 大流行期间 SARS-CoV-2 组织 PCR 阳性患者的系统尸检研究的死亡原因。
J Intern Med. 2021 Sep;290(3):655-665. doi: 10.1111/joim.13300. Epub 2021 May 20.
9
Causes of death and post-mortem testing for SARS-CoV-2 in a tertiary hospital during the COVID-19 pandemic in Ghana.加纳新冠疫情期间一家三级医院的新冠病毒死亡原因及尸检检测情况
Afr J Lab Med. 2022 Nov 23;11(1):1766. doi: 10.4102/ajlm.v11i1.1766. eCollection 2022.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.

引用本文的文献

1
Effects of Different Anticoagulation Doses on Moderate-to-Severe COVID-19 Pneumonia With Hypoxemia.不同抗凝剂量对中度至重度低氧血症型新冠肺炎肺炎的影响。
Cureus. 2023 Aug 12;15(8):e43389. doi: 10.7759/cureus.43389. eCollection 2023 Aug.
2
Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan.对约旦一系列病例中新冠病毒肺炎患者进行的尸检肺和心脏检查。
J Pathol Transl Med. 2023 Mar;57(2):102-112. doi: 10.4132/jptm.2023.01.30. Epub 2023 Mar 14.
3
Spread of COVID-19 Infection in Long-Term Care Facilities of Trieste (Italy) during the Pre-Vaccination Era, Integrating Findings of 41 Forensic Autopsies with Geriatric Comorbidity Index as a Valid Option for the Assessment of Strength of Causation.

本文引用的文献

1
Causes of death and comorbidities in hospitalized patients with COVID-19.COVID-19 住院患者的死亡原因和合并症。
Sci Rep. 2021 Feb 19;11(1):4263. doi: 10.1038/s41598-021-82862-5.
2
Undetectable SARS-CoV-2 in a nasopharyngeal swab but persistent viral RNA from deep lung swabs: findings from an autopsy.鼻咽拭子中未检测到严重急性呼吸综合征冠状病毒2(SARS-CoV-2),但深部肺拭子中存在持续的病毒RNA:尸检结果
BMJ Case Rep. 2020 Oct 31;13(10):e237446. doi: 10.1136/bcr-2020-237446.
3
Post-mortem ultrasonography: a safer alternative to autopsies in COVID-19 deaths.
意大利的里雅斯特长期护理机构在疫苗接种前时代新冠病毒感染的传播,整合41例法医尸检结果并以老年共病指数作为评估因果关系强度的有效选项
Vaccines (Basel). 2022 May 13;10(5):774. doi: 10.3390/vaccines10050774.
死后超声检查:COVID-19 死亡中比尸检更安全的选择。
J Ultrasound. 2021 Dec;24(4):577-578. doi: 10.1007/s40477-020-00531-1. Epub 2020 Oct 31.
4
The Role of COVID-19 in the Death of SARS-CoV-2-Positive Patients: A Study Based on Death Certificates.新型冠状病毒肺炎在严重急性呼吸综合征冠状病毒2阳性患者死亡中的作用:一项基于死亡证明的研究
J Clin Med. 2020 Oct 27;9(11):3459. doi: 10.3390/jcm9113459.
5
Response to the letter by Meng-jun Zhan et al. regarding the paper "A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19".对詹孟军等人就论文《来自意大利SARS-CoV-2疫情的技术报告。疑似或可能的COVID-19病例的尸检采样与解剖调查》所写信件的回复
Forensic Sci Med Pathol. 2020 Dec;16(4):746. doi: 10.1007/s12024-020-00324-2. Epub 2020 Oct 26.
6
Integrative analysis for COVID-19 patient outcome prediction.COVID-19 患者预后预测的综合分析。
Med Image Anal. 2021 Jan;67:101844. doi: 10.1016/j.media.2020.101844. Epub 2020 Oct 13.
7
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.利用 ISARIC WHO 临床特征协议对因 COVID-19 住院的患者进行风险分层:4C 死亡率评分的制定和验证。
BMJ. 2020 Sep 9;370:m3339. doi: 10.1136/bmj.m3339.
8
Guideline for medical certification of death in the COVID-19 era.2019冠状病毒病疫情期间死亡医学证明指南。
S Afr Med J. 2020 Jul 20;110(8):721-723.
9
[Deaths by COVID-19: Not all were registered and others should not be accounted for].[死于新冠病毒病:并非所有死亡都已登记,其他一些死亡不应计入]
Gac Sanit. 2021 Nov-Dec;35(6):590-593. doi: 10.1016/j.gaceta.2020.06.006. Epub 2020 Jul 19.
10
Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage.新冠肺炎患者死后病毒动力学和嗜性与器官损伤的相关性研究。
Virchows Arch. 2021 Feb;478(2):343-353. doi: 10.1007/s00428-020-02903-8. Epub 2020 Aug 20.